CollPlant Biotechnologies Ltd (CLGN) stock
CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
$3.96+0.06 (+1.54%)
Close on Nov 11, 2026Market cap $5.72MP/E –Yield –
CollPlant Biotechnologies revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $2.37M, up 360.4% from the year before. The highest annual figure on record is $15.64M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.37M | +360.4% |
| FY2024 | Dec 31, 2024 | $515.00K | -95.3% |
| FY2023 | Dec 31, 2023 | $10.96M | +3565.2% |
| FY2022 | Dec 31, 2022 | $299.00K | -98.1% |
| FY2021 | Dec 31, 2021 | $15.64M | +154.9% |
| FY2020 | Dec 31, 2020 | $6.14M | +164.8% |
| FY2019 | Dec 31, 2019 | $2.32M | -53.8% |
| FY2018 | Dec 31, 2018 | $5.01M | +982.9% |
| FY2017 | Dec 31, 2017 | $463.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | $179.00K | -74.1% |
| Q2 FY2024 | Jun 30, 2024 | $249.00K | -69.7% |
| Q2 FY2023 | Jun 30, 2023 | $10.18M | +1580.5% |
| Q2 FY2022 | Jun 30, 2022 | $66.00K | -63.7% |
| Q2 FY2021 | Jun 30, 2021 | $691.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $823.00K | – |
| Q2 FY2019 | Jun 30, 2019 | $606.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $182.00K | – |
See a number that looks wrong?